For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...
WellSquad on MSN3d
The Journey with Anxiety: How Long Do Anxiety Disorders Really Last?It’s hard to know how long anxiety disorders will last when you’re in the thick of them. It was during the mid-2000s that my ...
Johnson & Johnson is starting the year off strong with a $14.6 billion acquisition of the biopharma firm Intra-Cellular Therapies — best known for its blockbuster drug Caplyta. The deal was announced ...
Lexapro is used to treat major depressive disorder (depression) in adults and certain children. It’s also used to treat generalized anxiety disorder in adults. An interaction can occur because ...
Psychedelic drug company Mind Medicine Inc. (MindMed) (NASDAQ: MNMD) published its 2025 Investor Presentation this week with ...
Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement ...
Shares of Intra-Cellular Therapies Inc. (NASDAQ: ITCI) are trading higher Monday after Johnson & Johnson agreed to acquire the company.
A Vanderbilt team is setting out on a two-year project that aims to make AI chatbots more effective when part of behavioral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback